Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Learning about genomics and disease from the anucleate human red blood cell
Edward J. Benz Jr.
Edward J. Benz Jr.
Published November 22, 2010
Citation Information: J Clin Invest. 2010;120(12):4204-4206. https://doi.org/10.1172/JCI45433.
View: Text | PDF
Commentary

Learning about genomics and disease from the anucleate human red blood cell

  • Text
  • PDF
Abstract

During the differentiation of an erythrocyte, the developing erythroblast shuts down expression of most of its genes but preserves high levels of expression of certain key genes, such as those encoding hemoglobin and critical membrane proteins. In this issue of the JCI, Gallagher et al. show that a specialized type of DNA sequence element known as an insulator protects the expression of ankyrin, a key membrane protein. In several kindreds, mutations in the insulator led to impaired ankyrin expression and congenital hemolytic anemia. This work provides important insights into ways in which epigenetic changes can alter gene expression and thereby lead to human disease.

Authors

Edward J. Benz Jr.

×

Figure 1

Basic structure of the erythrocyte membrane and cytoskeleton.

Options: View larger image (or click on image) Download as PowerPoint
Basic structure of the erythrocyte membrane and cytoskeleton.
The diagra...
The diagram shows that the membrane is composed of a lipid bilayer punctuated by transmembrane proteins including Band3 and glycophorin C (GPC). The erythrocyte gains its strength and flexibility from the underlying cytoskeleton, which consists primarily of α- and β-spectrin. Spectrin (α- and β-spectrin) is attached flexibly to the membrane via ankyrin, which binds to Band 3, and via protein 4.1, which binds GPC. The other proteins shown enhance the strength of the binding. “Vertical interactions” provide strong attachments of the cytoskeleton to the lipid bilayer. “Horizontal interactions” allow the cell to stretch reversibly under shear stress without fragmentation. CaM, calmodulin; 4.1R80, 80-kDa erythrocyte isoform of protein 4.1R. Figure adapted from Frontiers in Bioscience (2).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts